Senior Director Biotechnology and Biotech-Services @ (March 2024 - April 2025)
VP, Data Integrity Officer and Chief of Staff to the COO @ (May 2023 - February 2024)
Head of Biosimilar Quality at Alvotech @ (January 2021 - May 2023)
Director Site Quality Head Bio MS and T and Contract Manufacturing Organisations, Bio CMO Ops. @ (April 2016 - January 2021)
Head of QA Auditing and CMO Surveillance @ (January 2014 - April 2016)
QA Manager Audits @ (August 2012 - January 2014)
QA Manager @ (August 2010 - July 2012)
CAPA Manager (QA) @ (February 2009 - July 2010)
Martin Baur Education
Law & Management | Executive School | University of St.Gallen
CAS General Management
2025-2026
Hochschule Furtwangen
Dipl. Ing. (Biotechnology)
2005-2009
Martin Baur Skills
21 CFR Part 11
ANVISA
Auditing
Belastbarkeit
Bilanzen
Biopharmaceuticals
Biotechnology
Business
CAPA
CCIT
CMO management
CMO overseight
Change Communications
Change Control
Change Management
Coaching
Communication
Consulting
Continuous Improvement
Contract Manufacturing
Cross-functional Team Leadership
DSP
Data Management
Design Control
Deviation Management
Electronic Data Capture (EDC)
Englisch
FDA
FDA GMP
GMP
Geschäftsbeziehungsmanagement
Gewinn- und Verlustrechnung
Good Manufacturing Practice (GMP)
Key Performance Indicators
Life Sciences
Manufacturing Operations
Manufacturing Operations Management
Matrix Management
Medical Devices
OOS
Operations
Pharmaceutical Industry
Project Management
Psychology
QC
Quality Assurance
Quality Control
Quality Management
Quality System
R&D
Regulatory Affairs
Regulatory Interactions
Regulatory Submissions
SOP
Sterile and Aseptic Fill and Finish
Strategie
Supplier Quality Management
Team Leadership
Technology Transfer
Transformationale Führung
Translationale Führung
Troubleshooting
USP
Unternehmensführung
Validation
Vertrieb
Wachstumsstrategien
Wettbewerbsstrategien
cGMP manufacturing
cGMP practices
Contract Negotiation
Microsoft Excel
Process Improvement
Sterile and Aseptic
Martin Baur Summary
Martin Baur, based in Germany, is currently a VP Corporate Development Biopharmaceuticals Technical Operations at Midas Pharma. Martin Baur brings experience from previous roles at Midas Pharma and Alvotech. Martin Baur holds a 2025 - 2026 CAS General Management @ Law & Management | Executive School | University of St.Gallen. With a robust skill set that includes 21 CFR Part 11, ANVISA, Auditing, Belastbarkeit, Bilanzen and more. Martin Baur has 1 emails on RocketReach.
Looking for a different Martin Baur?
Find contact details for 700 million professionals.